apaziquone News
Most Popular apaziquone Story
Allergan, Specturm ink $345.5M deal
Allergan and Spectrum Pharmaceuticals have signed a development and commercialization deal for apaziquone, an antineoplastic agent in Phase III testing for the treatment of non-muscle invasive Read more...
Latest Headlines
- October 29, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
